AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2012
Mar 8, 2012
31982_dirs_2012-03-08_bf656f7f-3717-4298-8af4-3f1cf6a324be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2012-03-01
Reporting Person: Glenn Gregory M (Chief Scientific Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-01 | Options-right to buy | $1.28 | A | 150000 | Acquired | 2022-03-01 | Common Stock (150000) | Direct |
Footnotes
F1: Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.